首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >A readily available assay for anti-immunoglobulin A: is this what we have been waiting for?
【24h】

A readily available assay for anti-immunoglobulin A: is this what we have been waiting for?

机译:一种现成的抗免疫球蛋白测定方法:这是我们一直在等待的东西吗?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Although anaphylactic transfusion reactions due to underlying immunoglobulin A deficiency (IgAD) are rare, it is not uncommon for transfusion medicine physicians to encounter patients with transfusion reactions with respiratory distress or hypotension, where the specter of anaphylaxis is raised. In such cases, IgAD with associated anti-IgA as the underlying cause must be excluded. Another common scenario is a patient with a purported history of IgAD, requiring a judgment in a limited time window as to whether special IgA-deficientblood components are needed for transfusion. In the majority of such cases, IgAD is not present in the patient, nor has it been an etiologic factor in a previous transfusion reaction. However, in most urgent situations, there are no diagnostic tests readily available to help us exclude the presence of IgAD or anti-IgA.
机译:尽管由于潜在的免疫球蛋白A缺乏症(IgAD)引起的过敏性输血反应很少见,但输血医学医师遇到患有呼吸窘迫或低血压的输血反应的患者并不少见,这会引起过敏反应。在这种情况下,必须排除具有相关抗IgA作为根本原因的IgAD。另一个常见的情况是患者有IgAD病史,需要在有限的时间范围内判断是否需要特殊的IgA缺乏血成分进行输血。在大多数此类情况下,患者中不存在IgAD,也不是先前输血反应中的病因。但是,在最紧急的情况下,没有可用的诊断测试可帮助我们排除IgAD或抗IgA的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号